How does hemolysis affect the accuracy of a lipid profile?

Effect of Hemolysis on Lipid Profile Accuracy

Hemolysis significantly interferes with lipid profile measurements, causing falsely elevated total cholesterol, triglycerides, LDL-C, and magnesium levels, while decreasing HDL-C, albumin, and other parameters—making hemolyzed samples unsuitable for accurate lipid assessment and requiring sample recollection.

Mechanism and Direction of Interference

Hemolysis creates both analytical and biological interference in lipid measurements through release of intracellular contents from lysed red blood cells. The interference pattern is approximately linearly dependent on the concentration of free hemoglobin in the specimen 1.

Parameters Falsely Elevated by Hemolysis:

• Total cholesterol - overestimated 2, 1
• Triglycerides - overestimated 2, 1
• LDL-C (calculated) - overestimated due to elevated cholesterol and triglycerides
• Creatine kinase, AST, ALT, LDH, magnesium, phosphorus, potassium 1

Parameters Falsely Decreased by Hemolysis:

• Albumin 1
• Alkaline phosphatase 2, 1
• GGT 1
• Glucose, sodium, chloride 1

Clinical Significance and Thresholds

Clinically meaningful variations occur even with mild or visually undetectable hemolysis (serum hemoglobin <0.6 g/L) 1. This is particularly problematic because:

• Visual inspection alone cannot reliably detect interference levels
• The heterogeneous and unpredictable response prevents reliable statistical correction
• Modern lipid treatment thresholds (e.g., LDL-C <1.80 mmol/L) require high accuracy 3

Magnitude of Interference

Research demonstrates that hemolysis interference varies with hemoglobin concentration up to 20.6 g/L, with the 10% variation threshold commonly used to define clinically significant interference 2. However, certain parameters show variable interference depending on baseline values:

• For normal values: interference may be present
• For pathological values: interference may disappear (e.g., creatinine, cholesterol, alkaline phosphatase, triglycerides) 2
• Inverse pattern: greater interference at pathological values (e.g., lipase, ALT) 2

Recommended Management Approach

When hemolysis is detected:

1. Quantify free hemoglobin in the specimen 1
2. Alert the ordering clinician immediately 1
3. Request sample recollection - this is the most reliable solution 1
4. Do not report results or clearly flag as unreliable if hemolysis is significant
5. Do not attempt mathematical correction - the unpredictable nature of interference makes this unreliable 1

Prevention Strategies

Since hemolysis is a major preanalytical variable, prevention focuses on:

• Proper phlebotomy technique (avoid prolonged tourniquet time >1 minute) 4
• Appropriate blood collection tubes
• Avoiding traumatic blood draws
• Proper sample handling and transport
• Timely processing

Special Considerations for Lipid Testing

The guidelines emphasize that fasting lipid profiles should be obtained whenever possible for accurate assessment 5. However, when hemolysis occurs:

• The Friedewald equation for calculating LDL-C becomes even more unreliable 5, 3
• Direct LDL-C measurement may be considered, but hemolysis still interferes 6
• Non-HDL-C calculations are also affected since they depend on total cholesterol 4

Common Pitfall: Attempting to use hemolyzed samples because the patient is difficult to draw or fasting is inconvenient. This compromises clinical decision-making, particularly when lipid-lowering therapy decisions depend on accurate baseline values 6.

Bottom Line: There is no acceptable workaround for hemolyzed lipid samples. The biological and analytical interference is too variable and unpredictable to allow reliable interpretation. Sample recollection is mandatory for accurate lipid assessment and appropriate clinical management 1.